Results 171 to 180 of about 35,966 (245)

MR molecular imaging for monitoring and predicting tumor responses to immunotherapy. [PDF]

Theranostics
Laney VEA, Zhao W, Hwang IM, Hampson E, Dong J, Hall RC, Weber-Bonk K, Yuan X, Delaney E, Gilmore H, Keri R, Winter J, Wang LL, Lu ZR.   +13 more
europepmc   +1 more source

Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines.

, 1990
Shlomo Z. Ben‐Sasson, Graham Le Gros, Daniel H. Conrad, Fred D. Finkelman, W E Paul   +4 more
openalex   +2 more sources

LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS LYSIS OF NORMAL AND NEOPLASTIC CELLS EXPRESSING TRANSFERRIN RECEPTORS(TR) [PDF]

, 1987
Gita Massey, Thalachallour Mohanakumar
openalex   +1 more source

Resting and sensitized T lymphocytes exhibit distinct stimulatory (antigen-presenting cell) requirements for growth and lymphokine release. [PDF]

, 1984
Kensuke Inaba, R M Steinman
openalex   +1 more source

Oral keratinocyte-mediated inflammation and epithelial disruption: A narrative review on IRF6 signaling and oral carcinogenic risk. [PDF]

Int J Immunopathol Pharmacol
Osorio-Osorno YA, Parada-Sanchez MT.
europepmc   +1 more source

Lymphokines

Immunobiology, 1981
openaire   +1 more source

Interleukin-2-inducible natural immune (lymphokine-activated killer cell) responses as a functional correlate of progression to AIDS

, 1994
Bluma Brenner, Mervyn Gornitsky, Mark A. Wainberg   +2 more
openalex   +2 more sources

Systemic administration of IL-2 induces lymphokine-activated killer (LAK) cells capable of killing macrophages in various tissues.

, 1989
Tetsu Kamitani, Haruo Suzuki, Saburo Yano   +2 more
openalex   +1 more source

Leukoregulin up-regulation of tumor cell sensitivity to natural killer and lymphokine-activated killer cell cytotoxicity

, 1989
Paulette M. Furbert-Harris, Charles H. Evans   +1 more
openalex   +2 more sources

Lifileucel: FDA-approved T-cell therapy for melanoma. [PDF]

Oncologist
Kwong MLM, Yang JC.
europepmc   +1 more source